rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses.

导出 OA

翻译打印收藏纠错

作者： Juan,Ye ^[1] ; Herui,Wang ^[1] ; Rogelio,Medina ^[1] ; Samik,Chakraborty ^[2] ; Mitchell,Sun ^[1] ; Alex,Valenzuela ^[1] ; Xueyu,Sang ^[3] ; Yaping,Zhang ^[4] ; Ondrej,Uher ^[1] ; Jan,Zenka ^[1] ; Karel,Pacak ^[5] ; Zhengping,Zhuang ^[6]

作者单位： Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 1000 37 Convent Dr, Bethesda, MD, 20892, USA. ^[1] NE1 Inc, New York, NY, USA. ^[2] David Geffen School of Medicine, University of California, Los Angeles, CA, USA. ^[3] Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA. ^[4] Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA. ^[5] Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic. ^[6] Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 1000 37 Convent Dr, Bethesda, MD, 20892, USA. zhengping.zhuang@nih.gov. ^[7]

关键词 Mannan-BAM Metastasis T-cell cytotoxicity TLR agonists rWTC-MBTA vaccine